Last reviewed · How we verify
Cryopreserved Umbilical Cord Allograft
Cryopreserved Umbilical Cord Allograft is a Biologic drug developed by Hackensack Meridian Health. It is currently in Phase 2 development.
At a glance
| Generic name | Cryopreserved Umbilical Cord Allograft |
|---|---|
| Sponsor | Hackensack Meridian Health |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients (PHASE2)
- AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft (PHASE2, PHASE3)
- Fetoscopic NEOX Cord 1K® Spina Bifida Repair (NA)
- Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders (NA)
- Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies (PHASE3)
- Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01) (PHASE2)
- Non-healing Diabetic Foot Ulcers (DFU) Treated With SoC With or Without NEOX®CORD 1K (NA)
- NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cryopreserved Umbilical Cord Allograft CI brief — competitive landscape report
- Cryopreserved Umbilical Cord Allograft updates RSS · CI watch RSS
- Hackensack Meridian Health portfolio CI
Frequently asked questions about Cryopreserved Umbilical Cord Allograft
What is Cryopreserved Umbilical Cord Allograft?
Cryopreserved Umbilical Cord Allograft is a Biologic drug developed by Hackensack Meridian Health.
Who makes Cryopreserved Umbilical Cord Allograft?
Cryopreserved Umbilical Cord Allograft is developed by Hackensack Meridian Health (see full Hackensack Meridian Health pipeline at /company/hackensack-meridian-health).
What development phase is Cryopreserved Umbilical Cord Allograft in?
Cryopreserved Umbilical Cord Allograft is in Phase 2.